FertilAI, an Israel-based company that develops AI-driven fertility treatment tools, has raised US$4.5 million.

The funding round was led by Longevity Venture Partners and Redseed, with additional participation from angel investors.

FertilAI offers AI solutions designed to assist doctors in clinical decision-making.

By 2024, more than 50 physicians worldwide are using FertilAI’s technology. This benefits over 20,000 patients.